Cleared Traditional

K121007 - NEO DELTA SELF SAFE T, NEO DELTA SELF SAFE T, NEO DELTA SELF SAFE 1, NEO DELTA SELF SAFE 1

K121007 is an FDA 510(k) clearance for NEO DELTA SELF SAFE T, manufactured by Delta Med Srl. The device is a Class 2 General Hospital device with product code FOZ cleared through the Traditional 510(k) pathway after a 269-day FDA review.

K121007 · Delta Med Srl · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2012
Decision
269d
Days
Class 2
Risk

K121007 is an FDA 510(k) clearance for the NEO DELTA SELF SAFE T, NEO DELTA SELF SAFE T, NEO DELTA SELF SAFE 1, NEO DELT.... Classified as Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days (product code FOZ), Class II - Special Controls.

Submitted by Delta Med Srl (Westmont, US). The FDA issued a Cleared decision on December 28, 2012 after a review of 269 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5200 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Delta Med Srl devices

FDA 510(k) Submission Details - K121007

510(k) Number K121007 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 03, 2012
Decision Date December 28, 2012
Days to Decision 269 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
140d slower than avg
Panel avg: 129d · This submission: 269d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FOZ Device Classification - Class 2, Special Controls

Product Code FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days

All 334
Devices cleared under the same product code (FOZ) and FDA review panel - the closest regulatory comparables to K121007.
POWERGLIDE MIDLINE CATHETER
K133856 · C.R. Bard, Inc. · Jan 2014
SAFETOUCH PSV WINGED INFUSION SET WITH/WITHOUT FILTER
K132153 · Nipro Medical Corporation · Dec 2013
BD NEXIVA DIFFUSICS CLOSED IV CATHETER SYSTEM
K123734 · Becton Dickinson Infusion Therapy Systems, Inc. · Jan 2013
POWERGLIDE MIDLINE CATHETER
K121073 · C.R. Bard, Inc. · Jun 2012
MULTI-MED CENTRAL VENOUS CATHETERS (CVCS), WITH AND WITHOUT HEPARIN VANTEX CENTRAL VENOUS CATHETERS (CVCS), WITH HEPARIN
K113565 · Edwards Lifesciences, LLC · May 2012
SUPERCATH Z3V
K112290 · Togo Medikit Co., Ltd. · Apr 2012